Cardiol Therapeutics (CRDL) Common Equity (2020 - 2026)
Cardiol Therapeutics' Common Equity came in at $17.37 million for Q2 2026, up 103.8% from $8.52 million a year earlier but down 1.6% from the prior quarter.
Cardiol Therapeutics (CRDL) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Cardiol Therapeutics' Common Equity was $12.8 million, down 29.2% from FY2024.
- Common Equity has declined in each of the last four years, though with a five-year compound annual growth rate of 5.3% (FY2020 to FY2025).
- Going back by year, Common Equity was $18.06 million in FY2024 (-12.9%), $20.75 million in FY2023 (-46.0%), $38.46 million in FY2022 (-36.8%) and $60.83 million in FY2021 (+514.1%).
- The five-year range for quarterly Common Equity is $6.95 million (Q3 2025) to $60.48 million (Q4 2021).
- Year-over-year, Common Equity increased in two of the last eight quarters, with an average decline of 2.0%.
- The fastest year-over-year change in Common Equity over five years came in Q4 2021 (growth of 494.2%), and the weakest in Q3 2024 (a decline of 70.6%).
- Business Quant data shows CRDL's Common Equity at $17.65 million (Q1 2026), $12.82 million (Q4 2025) and $6.95 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Cardiol Therapeutics | 169.43 Mn | 169.43 Mn | - | 17.37 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.37 Mn |
| Mar 31, 2026 | 17.65 Mn |
| Dec 31, 2025 | 12.82 Mn |
| Sep 30, 2025 | 6.95 Mn |
| Jun 30, 2025 | 8.52 Mn |
| Mar 31, 2025 | 12.26 Mn |
| Dec 31, 2024 | 17.70 Mn |
| Sep 30, 2024 | 7.65 Mn |
| Jun 30, 2024 | 11.23 Mn |
| Mar 31, 2024 | 14.89 Mn |
| Dec 31, 2023 | 20.75 Mn |
| Sep 30, 2023 | 26.01 Mn |
| Jun 30, 2023 | 28.85 Mn |
| Mar 31, 2023 | 33.70 Mn |
| Dec 31, 2022 | 38.46 Mn |
| Sep 30, 2022 | 44.99 Mn |
| Jun 30, 2022 | 49.30 Mn |
| Mar 31, 2022 | 54.64 Mn |
| Dec 31, 2021 | 60.48 Mn |
| Sep 30, 2021 | 23.11 Mn |
Cardiol Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CRDL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CRDL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CRDL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();